Fiebig, Timm
Romano, Maria Rosaria
Oldrini, Davide
Adamo, Roberto
Tontini, Marta
Brogioni, Barbara
Santini, Laura
Berger, Monika
Costantino, Paolo
Berti, Francesco
Gerardy-Schahn, Rita
Article History
Received: 10 May 2016
Revised: 14 July 2016
Accepted: 3 August 2016
First Online: 15 November 2016
Competing interests
: The authors MRR, DO, RA, MT, BB, LS, PC and FB are full-time employees of GSK Vaccines. The authors TF, MB and RG-S have submitted patent applications for glycoconjugate vaccines against <i>Nm</i>X.